N-Ac-DEVD-N′-(polyfluorobenzoyl)-R110: Novel cell-permeable fluorogenic caspase substrates for the detection of caspase activity and apoptosis

Bioconjugate Chemistry

Volumn 14, Issue 2, 2003, Pages 458-463

  Zhang, Han Zhong ^a   Kasibhatla, Shailaja ^a   Guastella, John ^a   Tseng, Ben ^a   Drewe, John ^a   Cai, Sui Xiong ^a  

^a Maxim Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASSAYS; CELL DEATH; CHLORINE COMPOUNDS;

CASPASE-3; CASPASES; CELL RETENTION; CELL-BASED; CELL-PERMEABLE; ENZYME ASSAYS; FLUOROGENICS; RETENTION PROPERTIES; RHODAMINE; TETRA PEPTIDE;

SUBSTRATES;

CASPASE; CASPASE 3; CHLORIDE; N (2,3,4,5 TETRAFLUOROBENZOYL)RHODAMINE; N (ACETYLASPARTYLGLUTAMYLVALYLASPARTYL) N' (2,3,4,5 TETRAFLUOROBENZOYL)RHODAMINE; N (ACETYLASPARTYLGLUTAMYLVALYLASPARTYL) N' PENTAFLUOROBENZOYLRHODAMINE; N PENTAFLUOROBENZOYLRHODAMINE; RECOMBINANT ENZYME; RHODAMINE; RHODAMINE 110; TETRAPEPTIDE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL STRAIN HL 60; CONTROLLED STUDY; ENZYMATIC DEGRADATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME SUBSTRATE; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; SYNTHESIS;

STAPHYLOCOCCUS PHAGE 3A;

EID: 0037345703     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc0256188     Document Type: Article

References (21)

1. Reed, J. C., and Tomaselli, K. J. (2000) Drug discovery opportunities from apoptosis research. Curr. Opin. Biotechnol. 11, 586-592.
2. Leung, D., Abbenante, G., and Fairlie, D. P. (2000) Protease inhibitors: current status and future prospects. J. Med. Chem. 43, 305-341.
3. Keppler-Hafkemeyer, A., Brinkmann, U., and Pastan, I. (1998) Role of caspases in immunotoxin-induced apoptosis of cancer cells. Biochemistry 37, 16934-16942.
4. Wellington, C. L., and Hayden, M. R. (2000) Caspases and neurodegeneration: on the cutting edge of new therapeutic approaches. Clin. Genet. 57, 1-10.
5. Lowe, S. W., and Lin, A. W. (2000) Apoptosis in cancer. Carcinogenesis 21, 485-495.
6. Thornberry, N. A. (1998) Caspases: key mediators of apoptosis. Chem. Biol. 5, R97-R103.
7. Kumar, S. (1999) Regulation of caspase activation in apoptosis: implications in pathogenesis and treatment of disease. Clin. Exp. Pharmacol. Physiol. 26, 295-303.
8. Stennicke, H. R., and Salvesen, G. S. J. (1997) Biochemical characteristics of caspases-3, -6, -7, and -8. Biol. Chem. 272, 25719-25723.
9. Liu, J., Bhalgat, M., Zhang, C., Diwu, Z., Hoyland, B., and Klaubert, D. H. (1999) Fluorescent molecular probes V: a sensitive caspase-3 substrate for fluorometric assays. Bioorg. Med. Chem. Lett. 9, 3231-3236.
10. Cai, S., Zhang, H., Guastella, J., Drewe, J., Yang, W., and Weber, E. (2001) Design and synthesis of rhodamine 110 derivative and caspase-3 substrate for enzyme- and cell-based fluorescent assay. Bioorg. Med. Chem. Lett. 11, 39-42.
11. Keana, J. F. W., and Cai, S. X. (1990) New reagents for photoaffinity labeling: Synthesis and photolysis of functionalized perfluorophenyl azides. J. Org. Chem. 55, 3640-3647.
12. Cai, S. X., Glenn, D. J., and Keana, J. F. W. (1992) Toward the development of radiolabeled fluorophenyl azide-based photolabeling reagents: synthesis and photolysis of iodinated 4-azido-perfluorobenzoates and 4-azido-3,5,6-trifluorobenzoates. J. Org. Chem. 57, 1299-1304.
13. Thornberry, N. A. (1994) Interleukin-1 beta converting enzyme. Methods Enzymol. 244, 615-631.
14. Casciola-Rosen, L. Nicholson, D. W., Chong, T., Rowan, K. R., Thornberry, N. A., Miller, D. K., and Rosen, A. (1996) Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J. Exp. Med. 183, 1957-64.
15. Falcieri, E., Martelli, A. M., Bareggi, R., Cataldi, A., and Cocco, L. (1993) The protein kinase inhibitor staurosporine induces morphological changes typical of apoptosis in MOLT-4 cells without concomitant DNA fragmentation. Biochem. Biophys. Res. Commun. 193, 19-25.
16. Jaeschke, H., Farhood, A., Cai, S. X., Tseng, B. Y., and Bajt, M. L. (2000) Protection against TNF-induced liver parenchymal cell apoptosis during endotoxemia by a novel caspase inhibitor in mice. Tox. App. Pharm. 169, 77-83.
17. Gee, K. R., Poot, M., Klaubert, D. H., Sun, W.-C., Haugland, R. P., and Mao, F. Fluorinated xanthene derivatives. US patent 6,162,931, column 76, example 132 and 133.
18. Shan, B., Medina, J. C., Santha, E., Frankmoelle, W. P., Chou, T. C., Learned, R. M., Narbut, M. R., Stott, D., Wu, P., Jaen, J. C., Rosen, T., Timmermans, P. B., and Beckmann, H. (1999) Selective covalent modification of beta-tubulin residue Cys-239 by T138067, an antitumor agent with in vivo efficacy against multidrug-resistant tumors. Proc. Natl. Acad. Sci. U.S.A. 96, 5686-5691.
19. 6 glioma cell apoptosis. Neurosci. Lett. 324, 33-36.
20. Thornberry, N. A., Rano, T. A., Peterson, E. P., Rasper, D. M., Timkey, T., Garcia-Calvo, M., Houtzager, V. M., Nordstrom, P. A., Roy, S., Vaillancourt, J. P., Chapman, K. T., and Nicholson, D. W. (1997) A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J. Biol. Chem. 272, 17907-17911.
21. Cai, S. X., Nguyen, B., Jia, S., Guastella, J., Reddy, S., Tseng, B., Drewe, J., and Kasibhatla, S. Discovery of substituted N-phenyl nicotinamides as potent inducers of apoptosis using a cell and caspase based high throughput screening assay. J. Med. Chem. submitted.